Regenerative medicine—which restores or replaces damaged tissues and organs through tissue engineering, and cellular and gene therapies—holds the potential to transform the way America approaches tissue repair, disease treatment, and organ replacement. However, bringing these technologies to market remains notoriously difficult due to complex manufacturing, regulatory, supply chain, and quality barriers.
The Regenerative Medicine Engine is addressing these challenges by strengthening infrastructure, streamlining pathways to commercialization, and developing a skilled regional workforce. This work is enabling top biotech innovators to build, grow, and scale their regenerative medicine companies in North Carolina’s core region, translating use-inspired regenerative medicine technologies into commercially available products where they can make a positive impact on everyday lives.
.png)
Lead organization: Wake Forest University School of Medicine.
Region of service: North Carolina.
NSF award: NSF-2315654
